Effects of Oral Administration of Malathion on the Course of Disease in MRL-lpr Mice

By Rodgers K.E.  

Journal of Autoimmunity, Vol. 10, Iss. 4, 1997-08 ,pp. : 367-373

Academic Press

Access to resources Recommend Favorite

Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice

By Kobayashi Toshihiko   Takahashi Koichiro   Nagai Yoshinori   Shibata Takuma   Otani Masako   Izui Shozo   Akira Shizuo   Gotoh Yoshiyuki   Kiyono Hiroshi   Miyake Kensuke  

International Immunology, Vol. 20, Iss. 7, 2008-07 ,pp. : 881-891

Oxford University Press

Access to resources Recommend Favorite

Enhanced Lymphoproliferation and Diminished Autoimmunity in CD4-deficient MRL/lpr Mice

By Chesnutt M.S.   Finck B.K.   Killeen N.   Connolly M.K.   Goodman H.   Wofsy D.  

Clinical Immunology, Vol. 87, Iss. 1, 1998-04 ,pp. : 23-32

Academic Press

Access to resources Recommend Favorite

Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice

By Clark Amy G.   Fan Qihua   Brady Graham F.   Mackin Katherine M.   Coffman Evan D.   Weston Melissa L.   Foster Mary H.  

Autoimmunity, Vol. 46, Iss. 3, 2013-05 ,pp. : 188-204

Informa Healthcare

Access to resources Recommend Favorite

Nucleolin as the Earliest Target Molecule of Autoantibodies Produced in MRL/lpr Lupus-Prone Mice

By Hirata D.   Iwamoto M.   Yoshio T.   Okazaki H.   Masuyama J-i.   Mimori A.   Minota S.  

Clinical Immunology, Vol. 97, Iss. 1, 2000-10 ,pp. : 50-58

Academic Press

Access to resources Recommend Favorite